Description:
BREAST CANCER, TYPE 1; BRCA1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Class |
Heritable Cancer Syndromes and other Cancers |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization after cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
BRCA1 |
Chromosomal Location |
17q21.31 |
Allelic Variant 1 |
113705.0018; BREAST-OVARIAN CANCER |
Identified Mutation |
1-BP INS, 5382C; Simard et al. [Nature Genetics 8: 392-398 (1994)] studied 30 Canadian families with breast and/or ovarian cancer for germline mutations in the coding region of the BRCA1 candidate gene. They identified a 1-bp (C) insertion at position 5382 in exon 20, changing the reading frame of the mRNA and causing a premature termination codon at position 1829 in exon 24. |
Remarks |
Diagnosed at age 40; mother with ovarian cancer and 2 other relatives with breast cancer; BRCA1 germline mutation is 5382insC in exon 20, codon 1755 |
Loke J, Alim I, Yam S, Klugman S, Xia LC, Gruber D, Tegay D, LaBella A, Onel K, Ostrer H, Prediction of breast cancer risk based on flow variant analysis of circulating peripheral blood mononuclear cells HGG advances3:100085 2021 |
PubMed ID: 35146455 |
|
Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, Tucker MA, Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet57:1-7 1995 |
PubMed ID: 7611277 |
dbSNP |
dbSNP ID: 12005 |
Gene Cards |
BRCA1 |
Gene Ontology |
GO:0000151 ubiquitin ligase complex |
|
GO:0003684 damaged DNA binding |
|
GO:0003713 transcription coactivator activity |
|
GO:0004842 ubiquitin-protein ligase activity |
|
GO:0005515 protein binding |
|
GO:0005615 extracellular space |
|
GO:0005622 intracellular |
|
GO:0005634 nucleus |
|
GO:0005667 transcription factor complex |
|
GO:0006357 regulation of transcription from Pol II promoter |
|
GO:0006359 regulation of transcription from Pol III promoter |
|
GO:0006978 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
|
GO:0008270 zinc ion binding |
|
GO:0008274 gamma-tubulin ring complex |
|
GO:0015631 tubulin binding |
|
GO:0016563 transcriptional activator activity |
|
GO:0016567 protein ubiquitination |
|
GO:0042127 regulation of cell proliferation |
|
GO:0042981 regulation of apoptosis |
|
GO:0045739 positive regulation of DNA repair |
|
GO:0045786 negative regulation of cell cycle |
|
GO:0046600 negative regulation of centriole replication |
NCBI Gene |
Gene ID:672 |
NCBI GTR |
113705 BREAST CANCER 1 GENE; BRCA1 |
|
604370 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1 |
OMIM |
113705 BREAST CANCER 1 GENE; BRCA1 |
|
604370 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1 |
Omim Description |
BREAST CANCER 1, EARLY-ONSETBREAST-OVARIAN CANCER, INCLUDED |
|
BREAST CANCER, TYPE 1; BRCA1 |
|
|